| PERIOD ENDING | 31-Dec-05 | 31-Dec-04 | 31-Dec-03 | | Total Revenue | 297,743 | 284,130 | 315,458 | | Cost of Revenue | 128,690 | 119,404 | 102,454 | | | Gross Profit | 169,053 | 164,726 | 213,004 | | | Operating Expenses | | Research Development | 45,767 | 41,943 | 40,601 | | Selling General and Administrative | 108,099 | 123,299 | 97,718 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 15,187 | (516) | 74,685 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,609) | (6,417) | 991 | | Earnings Before Interest And Taxes | 13,578 | (6,933) | 75,676 | | Interest Expense | 6,284 |
-
| 2,720 | | Income Before Tax | 7,294 | (6,933) | 72,956 | | Income Tax Expense | 1,617 | (16,991) | 11,475 | | Minority Interest |
-
| 1,017 | (326) | | | | Net Income From Continuing Ops | 5,677 | 11,075 | 61,155 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 5,677 | 11,075 | 61,155 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,677 | $11,075 | $61,155 |
|
0.63% Nasdaq 
0.03%
Income Statement
